AT&T INC. Quarterly Liabilities, Current in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
At&T Inc. quarterly Liabilities, Current history and growth rate from Q1 2010 to Q3 2024.
  • At&T Inc. Liabilities, Current for the quarter ending September 30, 2024 was $40.7B, a 21.3% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $40.7B -$11B -21.3% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $42.4B -$11.7B -21.7% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $44.8B -$13.3B -22.9% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $51.1B -$5.05B -8.98% Dec 31, 2023 10-Q 2024-10-29
Q3 2023 $51.7B -$573M -1.1% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $54.2B +$4.97B +10.1% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $58.2B -$24.3B -29.5% Mar 31, 2023 10-Q 2023-05-01
Q4 2022 $56.2B -$50.1B -47.1% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $52.3B -$29.3B -36% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $49.2B -$32.9B -40.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $82.5B +$5.89B +7.68% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $106B +$42.8B +67.5% Dec 31, 2021 10-K 2023-02-13
Q3 2021 $81.6B +$22B +37% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $82.1B +$12.7B +18.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $76.6B +$6.9B +9.91% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $63.4B -$5.47B -7.94% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $59.6B -$8.56B -12.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $69.5B +$3.09B +4.66% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $69.7B +$5.05B +7.81% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $68.9B +$4.49B +6.97% Dec 31, 2019 8-K 2021-06-21
Q3 2019 $68.1B +$2.71B +4.14% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $66.4B -$2.22B -3.23% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $64.7B -$5.93B -8.4% Mar 31, 2019 10-Q/A 2019-05-07
Q4 2018 $64.4B -$17B -20.8% Dec 31, 2018 10-K 2020-02-20
Q3 2018 $65.4B +$17.7B +37.2% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $68.6B +$20.6B +42.9% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $70.6B +$19.9B +39.2% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $81.4B +$30.8B +60.9% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $47.7B +$591M +1.26% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $48B +$1.55B +3.33% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $50.7B +$6.16B +13.8% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $50.6B +$2.76B +5.77% Dec 31, 2016 8-K 2018-10-12
Q3 2016 $47.1B -$836M -1.74% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $46.5B +$5.94B +14.7% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $44.5B +$6.88B +18.3% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $47.8B +$10.5B +28.3% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $47.9B +$7.96B +19.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $40.5B -$3.26B -7.45% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $37.7B -$2.18B -5.47% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $37.3B +$2.29B +6.54% Dec 31, 2014 10-K 2016-02-18
Q3 2014 $40B +$3.8B +10.5% Sep 30, 2014 10-Q/A 2014-11-10
Q2 2014 $43.8B +$12.6B +40.4% Jun 30, 2014 10-Q 2014-11-10
Q1 2014 $39.8B +$10B +33.7% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $35B +$3.21B +10.1% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $36.2B +$5.39B +17.5% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 $31.2B +$1.49B +5.01% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 $29.8B -$2.73B -8.41% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $31.8B +$895M +2.9% Dec 31, 2012 10-K 2014-02-21
Q3 2012 $30.8B -$3.23B -9.5% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $29.7B -$3.84B -11.4% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 $32.5B -$734M -2.21% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $30.9B -$3.96B -11.4% Dec 31, 2011 10-K 2013-02-22
Q3 2011 $34B +$1.36B +4.15% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $33.5B -$2.65B -7.31% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $33.3B -$3.45B -9.4% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $34.9B Dec 31, 2010 10-K 2012-02-24
Q3 2010 $32.7B Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $36.2B Jun 30, 2010 10-Q 2010-08-06
Q1 2010 $36.7B Mar 31, 2010 10-Q 2010-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.